Epidemiology of atopic dermatitis and atopic march in children
- PMID: 20670812
- DOI: 10.1016/j.iac.2010.06.003
Epidemiology of atopic dermatitis and atopic march in children
Abstract
Atopic dermatitis (AD) is one of the most common chronic childhood skin diseases affecting up to 17% of children in the United States. The point prevalence of AD has increased based on validated questionnaires in the most recent update of the International Study of Asthma and Allergies in Childhood. However, the increases are primarily in developing countries, whereas the rates have stabilized in countries with higher incomes. AD starts in early childhood with 65% of children affected by 18 months of age. Furthermore, less than half of the patients with AD have complete resolution by 7 years of age and only 60% have resolution by adulthood, indicating the chronic nature of AD. AD is a major risk factor for the development of asthma, with an increased odds ratio in children with AD in several longitudinal studies compared with children without AD, and about 30% of patients with AD develop asthma. Patients with atopic sensitization along with eczema are at a higher risk for progressing in the atopic march to asthma. The main risk factors for progression and persistence of asthma are early onset and severity of AD.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children.Arch Dermatol. 2006 May;142(5):561-6. doi: 10.1001/archderm.142.5.561. Arch Dermatol. 2006. PMID: 16702493
-
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma.J Allergy Clin Immunol. 2004 May;113(5):925-31. doi: 10.1016/j.jaci.2004.01.778. J Allergy Clin Immunol. 2004. PMID: 15131576
-
Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review.
-
[From atopic dermatitis to asthma].Allergol Immunopathol (Madr). 1998 May-Jun;26(3):114-9. Allergol Immunopathol (Madr). 1998. PMID: 9675392 Review. Spanish.
-
Prevalence and risk factors for atopic dermatitis in preschool children.Br J Dermatol. 2008 Mar;158(3):539-43. doi: 10.1111/j.1365-2133.2007.08344.x. Epub 2007 Dec 7. Br J Dermatol. 2008. PMID: 18067476
Cited by
-
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.Int J Mol Sci. 2021 Mar 10;22(6):2805. doi: 10.3390/ijms22062805. Int J Mol Sci. 2021. PMID: 33802091 Free PMC article. Review.
-
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.Pharmacoepidemiol Drug Saf. 2023 May;32(5):567-576. doi: 10.1002/pds.5586. Epub 2022 Dec 28. Pharmacoepidemiol Drug Saf. 2023. PMID: 36527432 Free PMC article.
-
Dissociating polysensitization and multimorbidity in children and adults from a Polish general population cohort.Clin Transl Allergy. 2019 Feb 11;9:4. doi: 10.1186/s13601-019-0246-y. eCollection 2019. Clin Transl Allergy. 2019. PMID: 30792849 Free PMC article.
-
Potential Role of Omega-3 Polyunsaturated Fatty Acids in Pediatric Food Allergy.Nutrients. 2021 Dec 29;14(1):152. doi: 10.3390/nu14010152. Nutrients. 2021. PMID: 35011028 Free PMC article. Review.
-
Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.J Allergy Clin Immunol. 2015 Apr;135(4):930-935.e1. doi: 10.1016/j.jaci.2014.12.013. Epub 2015 Jan 22. J Allergy Clin Immunol. 2015. Retraction in: J Allergy Clin Immunol. 2021 Apr;147(4):1526. doi: 10.1016/j.jaci.2021.02.002. PMID: 25618747 Free PMC article. Retracted.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical